Company Filing History:
Years Active: 2018-2025
Title: Akiyoshi Hirayama: Innovator in Medical Detection and Electrophoresis
Introduction
Akiyoshi Hirayama is a notable inventor based in Tsuruoka, Japan. He has made significant contributions to the fields of medical detection and electrophoresis, holding a total of 2 patents. His work focuses on developing methods that enhance diagnostic accuracy and improve measurement techniques.
Latest Patents
Hirayama's latest patents include a method for detecting systemic lupus erythematosus (SLE). This innovative method allows for high-accuracy detection of SLE without the need for a renal biopsy. The process involves measuring the concentration of 3',4'-didehydro-3'-deoxycytidine in urine and comparing it to a reference concentration. This comparison enables the detection of whether a subject has SLE, particularly lupus nephritis, with high precision. Another significant patent involves the creation of a spray device for sheathless capillary electrophoresis-mass spectrometry (CE-MS). This device features a capillary with an acute-angle distal end and an electrophoretic liquid passing hole, which is securely bonded to an insulating plate. This design allows for high-sensitivity measurements using the spray device.
Career Highlights
Throughout his career, Akiyoshi Hirayama has worked with prestigious institutions such as Keio University and the National University Corporation National Higher Education and Research System. His experience in these organizations has contributed to his expertise in medical and technological innovations.
Collaborations
Hirayama has collaborated with notable colleagues, including Tomoyoshi Soga and Hiroshi Abe. These partnerships have likely enriched his research and development efforts, leading to impactful inventions.
Conclusion
Akiyoshi Hirayama's contributions to medical detection and electrophoresis exemplify the importance of innovation in improving diagnostic methods. His patents reflect a commitment to advancing technology for better healthcare outcomes.